Skip Navigation

Cardiovascular Research 2002 55(2):261-269; doi:10.1016/S0008-6363(02)00405-4
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Mead, J. R
Right arrow Articles by Ramji, D. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mead, J. R
Right arrow Articles by Ramji, D. P
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

The pivotal role of lipoprotein lipase in atherosclerosis

James R Mead and Dipak P Ramji*

Cardiff School of Biosciences, Cardiff University, Museum Avenue, P.O. Box 911, Cardiff CF10 3US, UK

* Corresponding author. Tel.: +44-29-2087-6753; fax: +44-29-2087-6753 ramji@cardiff.ac.uk

Received 21 December 2001; accepted 5 March 2002

KEYWORDS apoE, apolipoprotein E; HSPG, heparan sulphate proteoglycans; IFN-{gamma}, interferon-{gamma}; LPL, lipoprotein lipase; LRP, LDL receptor-related protein; M-CSF, macrophage colony stimulating factor; TNF-{alpha}, tumour necrosis factor-{alpha}

The first 150 words of the full text of this article appear below.


   1. Introduction
 
Atherosclerosis, the underlying cause of heart attacks, stroke and peripheral vascular disease, is responsible for over 50% of all deaths in developed countries. The disease can generally be viewed as a form of chronic inflammation that is induced and perturbed by lipid accumulation and involves a number of components, including the damaged endothelium, monocytes/macrophages, T cells, smooth muscle cells and a regulatory network of growth factors and cytokines (see Refs. [1,2] for reviews). The process is believed to be triggered by damage to the arterial endothelial cells leading to dramatic changes in their properties and increased expression of both chemokines and adhesion molecules [1,2]. This causes an infiltration of both T lymphocytes and monocytes to the site of damage. The monocytes then differentiate into macrophages, internalise lipoproteins, and transform into lipid-loaded foam cells to form the fatty streak seen in early lesions [1,2]. This transformation of macrophages into . . . [Full Text of this Article]


   2. Pro-atherogenic actions of LPL
 

   3. Importance of LPL expression in the atherosclerotic lesion
 

   4. The catalytic action of LPL induces the formation of atherogenic lipoprotein remnants
 

   5. LPL acts as an atherogenic ligand
 

   6. Anti-atherogenic nature of LPL
 

   7. Regulation of LPL by factors implicated in atherogenesis
 

   8. Concluding remarks
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?